|
HY-P71764-100ug
|
MedChemexpress LLC
|
NPR1, Human (P.pastoris, His)
|
|
|
|
|
HY-P71764-20ug
|
MedChemexpress LLC
|
NPR1, Human (P.pastoris, His)
|
|
|
|
|
HY-P71764-50ug
|
MedChemexpress LLC
|
NPR1, Human (P.pastoris, His)
|
|
|
|
|
HY-P2148-1mg
|
MedChemexpress LLC
|
P-113 [CAS 190673-58-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-P2148-10mg
|
MedChemexpress LLC
|
P-113 [CAS 190673-58-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-P2148-5mg
|
MedChemexpress LLC
|
P-113 [CAS 190673-58-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-P72271-10ug
|
MedChemexpress LLC
|
TRAC, Human (P.pastoris, His)
|
|
|
|
|
HY-P72271-2ug
|
MedChemexpress LLC
|
TRAC, Human (P.pastoris, His)
|
|
|
|
|
HY-P72271-50ug
|
MedChemexpress LLC
|
TRAC, Human (P.pastoris, His)
|
|
|
|
|
HY-P72303-10ug
|
MedChemexpress LLC
|
Atrial natriuretic peptide receptor 2/NPR2, Human (His)
|
|
|
|
|
HY-P72303-2ug
|
MedChemexpress LLC
|
Atrial natriuretic peptide receptor 2/NPR2, Human (His)
|
|
|
|
|
HY-P72303-50ug
|
MedChemexpress LLC
|
Atrial natriuretic peptide receptor 2/NPR2, Human (His)
|
|
|
|
|
HY-16707-10mg
|
MedChemexpress LLC
|
CH 5450 [CAS 252557-97-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-16707-5mg
|
MedChemexpress LLC
|
CH 5450 [CAS 252557-97-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-16707-50mg
|
MedChemexpress LLC
|
CH 5450 [CAS 252557-97-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-16707-1mL
|
MedChemexpress LLC
|
CH 5450 [CAS 252557-97-4] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-P71729-10ug
|
MedChemexpress LLC
|
DCD, Human (P.pastoris, His)
|
|
|
|
|
HY-P71729-5ug
|
MedChemexpress LLC
|
DCD, Human (P.pastoris, His)
|
|
|
|
|
HY-P71729-50ug
|
MedChemexpress LLC
|
DCD, Human (P.pastoris, His)
|
|
|
|
|
HY-P99263-1mg
|
MedChemexpress LLC
|
Inclacumab [CAS 1256258-86-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P99263-10mg
|
MedChemexpress LLC
|
Inclacumab [CAS 1256258-86-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P99263-5mg
|
MedChemexpress LLC
|
Inclacumab [CAS 1256258-86-2]
|
|
Neuroscience-Neuromodulation
|
|
